Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,26 USD | -3,52% | -6,20% | -13,23% |
Vakgebied
Aantal werknemers: 56
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01-04-17 |
Timothy Rolph
FOU | Founder | 70 | 01-04-17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01-09-18 |
William White
DFI | Director of Finance/CFO | 51 | 01-04-19 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01-05-22 |
Patrick Lamy
PRN | Corporate Officer/Principal | - | 01-01-23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01-10-18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01-01-17 |
Jane Henderson
BRD | Director/Board Member | 59 | 23-04-19 |
Mark Iwicki
CHM | Chairman | 57 | 01-11-18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01-09-18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09-06-20 |
Jonathan Young
FOU | Founder | 54 | 01-04-17 |
Judy Chou
BRD | Director/Board Member | 58 | 12-07-21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01-06-18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 68 404 445 | 58 254 289 ( 85,16 %) | 0 | 85,16 % |
Bedrijfsgegevens
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,23% | 1,45 mld. | |
-1,51% | 105 mld. | |
+3,22% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,53% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,09% | 14,52 mld. | |
+5,47% | 14,09 mld. | |
+28,85% | 10,99 mld. |
- Beurs
- Aandelen
- Koers AKRO
- Onderneming Akero Therapeutics, Inc.